Edward Lang, DPM
Podiatrist · New Orleans, LANPI 1699798769
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $4,460 of the $7,255 with a category attached, or 61.5%. 15 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 53.5% of the total. 2025 is the largest year on record at $2,017, 3.0 times the $669 reported in 2019.
Across 140 payments — averaging $51.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$4K
- ALON Medical Technology$901
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$832
- Arthrex$406
- Stryker$349
- Zyla Life Sciences, Inc.$226
- plus $661 from 9 others
What the payments were for
- Consulting fees$6809%
- Travel & lodging$4,46061%
- Food & beverage$2,10629%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 17 | $3,879 |
| ALON Medical Technology | 3 | $901 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 26 | $832 |
| Arthrex | 6 | $406 |
| Stryker | 13 | $349 |
| Zyla Life Sciences, Inc. | 32 | $226 |
| Zimmer Biomet | 5 | $196 |
| Assertio Therapeutics, Inc. | 19 | $162 |
| Amgen | 12 | $135 |
| Biopoly LLC | 1 | $76 |
| Pfizer | 2 | $29 |
| Melinta Therapeutics, LLC | 1 | $21 |
| Merck | 1 | $16 |
| Smith+Nephew | 1 | $13 |
| Alfasigma USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$2,643
- Lapiplasty$798
- JUBLIA$680
How this compares
$7,255 in reported general payments places this provider in the 75th percentile of 68 podiatrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 120 | $2,616 |
| CiclopiroxCiclopirox Olamine | 122 | $2,340 |
| Mupirocin | 57 | $924 |
| Ciclopirox | 20 | $817 |
| Cefdinir | 57 | $540 |
| Celecoxib | 24 | $326 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $305 |
| Doxycycline Hyclate | 17 | $227 |
| Methylprednisolone | 29 | $209 |
| Naproxen | 23 | $149 |
| Terbinafine Hcl | 29 | $122 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $77 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in New Orleans
- Nneka MekaNew Orleans$9K
- Dayna BoltonNew Orleans$9K
- Sandreka JonesNew Orleans$6K
- Erin BujolNew Orleans$3K
- Nhu HoangNew Orleans$3K
- Giang NguyenNew Orleans$2K
- Joshua NeesonNew Orleans$1K
- Maxime SavardKenner$74K
- David TranMonroe$24K
- Tyler TewilliagerHouma$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.